Jagsonpal Pharmaceuticals227.44
+0.63 (+0.28%)

Jagsonpal Pharmaceuticals Share Price

227.44+0.63 (+0.28%)
-6.43% past 1 Year

Corporate filings & documents

Announcements

Voting Result and scrutinizer Report of 47th Annual General Meeting.
16 hours ago
Voting Result and scrutinizer Report of 47th Annual General Meeting.
16 hours ago
Summary of Proceedings of 47th Annual General Meeting.
3 days ago
Summary of Proceedings of 47th Annual General Meeting.
3 days ago
Newspaper Publication for dispatch of Notice of 47th Annual General Meeting Annual Report 2025-26 and e-voting
3 weeks ago
Newspaper Publication for dispatch of Notice of 47th Annual General Meeting Annual Report 2025-26 and e-voting
3 weeks ago
Notice of 47th of Annual General Meeting and Annual Report for F.Y. 2025-26
3 weeks ago
Notice of 47th of Annual General Meeting and Annual Report for F.Y. 2025-26
3 weeks ago
BRSR for the Financial year ended March 31 2026
3 weeks ago
BRSR for the Financial year ended March 31 2026
3 weeks ago
Annual report for Financial Year 2025-26
3 weeks ago
Annual report for Financial Year 2025-26
3 weeks ago
Letter providing a web link of annual report 2025-26 to members.
3 weeks ago
Letter providing a web link of annual report 2025-26 to members.
3 weeks ago
Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee stock option Plan 2022
4 weeks ago
Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee stock option Plan 2022
4 weeks ago
Newspaper Advertisement- 47th Annual General Meeting of the Company to be held on September 18 2026
1 month ago
Newspaper Advertisement- 47th Annual General Meeting of the Company to be held on September 18 2026
1 month ago
Earning Call Transcript for meeting held on July 30 2026
1 month ago
Earning Call Transcript for meeting held on July 30 2026
1 month ago
Audio Recording of Jagsonpal Pharmaceuticals Limited Q1 FY27 Earnings Conference Call on July 30 2026 at 2:30 P.M.
1 month ago
Audio Recording of Jagsonpal Pharmaceuticals Limited Q1 FY27 Earnings Conference Call on July 30 2026 at 2:30 P.M.
1 month ago
Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30 2026
1 month ago
Newspaper Publication of Unaudited Financial Results of the Company for the quarter ended June 30 2026
1 month ago
Change in Senior Management personnel of the Company
1 month ago
Change in Senior Management personnel of the Company
1 month ago
Corporate Action- Record Date for dividend Purpose: September 04 2026
1 month ago
Corporate Action- Record Date for dividend Purpose: September 04 2026
1 month ago
Intimation for grant of Employee Stock Options
1 month ago
Intimation for grant of Employee Stock Options
1 month ago
Press Release for Unaudited Financial results for quarter ended June 30 2026
1 month ago
Press Release for Unaudited Financial results for quarter ended June 30 2026
1 month ago
Press Release for Unaudited Financial Results for quarter ended June 30 2026
1 month ago
Press Release for Unaudited Financial Results for quarter ended June 30 2026
1 month ago
Unaudited results along with its Limited Review Report for the quarter ended June 30 2026
1 month ago
Unaudited results along with its Limited Review Report for the quarter ended June 30 2026
1 month ago
Outcome of Board Meeting held on July 29 2026 along with Unaudited (Standalone) Financial Results for the quarter June 30 2026
1 month ago
Outcome of Board Meeting held on July 29 2026 along with Unaudited (Standalone) Financial Results for the quarter June 30 2026
1 month ago
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company as a part of its investors engagement activities has scheduled a conference call with the Analysts / Investors on Thursday July 30 2026 to discuss its Q1 FY27 financial results. The Conference call details is attached as Annexure.
2 months ago
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Company as a part of its investors engagement activities has scheduled a conference call with the Analysts / Investors on Thursday July 30 2026 to discuss its Q1 FY27 financial results. The Conference call details is attached as Annexure.
2 months ago
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 inter alia to consider and approve the unaudited Financial Results of the Company for the quarter ended June 30 2026
2 months ago
Jagsonpal Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2026 inter alia to consider and approve the unaudited Financial Results of the Company for the quarter ended June 30 2026
2 months ago
Updates on Acquisition of Aequitas Healthcare Private Limited.
2 months ago
Updates on Acquisition of Aequitas Healthcare Private Limited.
2 months ago
Allotment of 94 000 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan 2022.
2 months ago
Allotment of 94 000 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan 2022.
2 months ago
Updates on Acquisition of Aequitas Healthcare Private Limited
2 months ago
Updates on Acquisition of Aequitas Healthcare Private Limited
2 months ago
Updates on Acquisition of Aequitas Healthcare Private Limited.
2 months ago
Updates on Acquisition of Aequitas Healthcare Private Limited.
2 months ago

Concalls & investor presentations

Jul 2026
ConcallPresentation
Jul 2026
Apr 2026
ConcallPresentation
Apr 2026
Jan 2026
ConcallPresentation
Jan 2026
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
Jul 2025
May 2025
ConcallPresentation
May 2025
Jan 2025
ConcallPresentation
Jan 2025
Oct 2024
ConcallPresentation
Oct 2024
Aug 2022
Feb 2022

Jagsonpal Pharmaceuticals Ltd Share Price Today

The Jagsonpal Pharmaceuticals Ltd share price today is ₹240.38. During the trading session, the Jagsonpal Pharmaceuticals Ltd share price opened at ₹242.06 and recorded an intraday high of ₹247.96 and a low of ₹239.96. Last closing price was ₹242.06. Over the past 52 weeks, the Jagsonpal Pharmaceuticals Ltd share price has ranged between ₹155.00 and ₹264.50. The current Jagsonpal Pharmaceuticals Ltd stock price reflects real-time market activity based on executed trades on the exchange.